1. Home
  2. IMNN vs TAIT Comparison

IMNN vs TAIT Comparison

Compare IMNN & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • TAIT
  • Stock Information
  • Founded
  • IMNN 1982
  • TAIT 1989
  • Country
  • IMNN United States
  • TAIT United States
  • Employees
  • IMNN N/A
  • TAIT N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • IMNN Health Care
  • TAIT Technology
  • Exchange
  • IMNN Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • IMNN 12.9M
  • TAIT 15.1M
  • IPO Year
  • IMNN 1985
  • TAIT 1995
  • Fundamental
  • Price
  • IMNN $4.39
  • TAIT $2.24
  • Analyst Decision
  • IMNN Buy
  • TAIT
  • Analyst Count
  • IMNN 2
  • TAIT 0
  • Target Price
  • IMNN $182.61
  • TAIT N/A
  • AVG Volume (30 Days)
  • IMNN 79.1K
  • TAIT 184.9K
  • Earning Date
  • IMNN 11-05-2025
  • TAIT 11-14-2025
  • Dividend Yield
  • IMNN N/A
  • TAIT 8.93%
  • EPS Growth
  • IMNN N/A
  • TAIT N/A
  • EPS
  • IMNN N/A
  • TAIT N/A
  • Revenue
  • IMNN N/A
  • TAIT $4,203,000.00
  • Revenue This Year
  • IMNN N/A
  • TAIT N/A
  • Revenue Next Year
  • IMNN N/A
  • TAIT N/A
  • P/E Ratio
  • IMNN N/A
  • TAIT N/A
  • Revenue Growth
  • IMNN N/A
  • TAIT N/A
  • 52 Week Low
  • IMNN $4.33
  • TAIT $2.01
  • 52 Week High
  • IMNN $41.22
  • TAIT $5.10
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 30.98
  • TAIT 41.29
  • Support Level
  • IMNN $4.44
  • TAIT $2.27
  • Resistance Level
  • IMNN $4.90
  • TAIT $2.72
  • Average True Range (ATR)
  • IMNN 0.32
  • TAIT 0.14
  • MACD
  • IMNN -0.04
  • TAIT -0.02
  • Stochastic Oscillator
  • IMNN 2.09
  • TAIT 28.65

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: